Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The impact of cystic fibrosis-related diabetes on health-related quality of life.J Cystic Fibrosis. 2019; : 7-9
- Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.Diabetes Care. 2010; 33: 2697-2708
- Cystic fibrosis related diabetes: Revisiting the OGTT and alternate screening tests.J Cyst Fibros. 2020; 19: 671-672
- HbA1c as a screening tool for cystic fibrosis related diabetes.J Cyst Fibros. 2016; 15: 251-257
- Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.J Cyst Fibros. 2016; 15: 258-260
- Cystic fibrosis-related diabetes screening in adults: a Gap analysis and evaluation of accuracy of Glycated hemoglobin levels.Can J Diabetes. 2019; 43: 13-18
- Abnormal glucose tolerance and the 50-gram glucose challenge test in Cystic fibrosis.J Cyst Fibros. 2020; 19: 696-699
- Glucose >200 mg/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes.J Diabetes Res. 2016; 20161527932
Chan CL, Pyle L, Vigers T, Zeitler PS, Nadeau KJ.J Clin Endocrinol Metab. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis. 2022 Jan 18;107(2):e548-e560. doi: 10.1210/clinem/dgab692.PMID: 34537845.
- Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.Endocrinol Diabetes Nutr (Engl Ed. 2018; 65: 45-51
- Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring.J Cyst Fibros. 2021; 20: 779-784
- Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis.Front Pediatr. 2021; 9659728
- Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.J Cyst Fibros. 2018; 17: 783-790
- Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?.J Cyst Fibros. 2017; 16: 628-630
- Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.J Cyst Fibros. 2014; 13: 478-484
- The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.J Cyst Fibros. 2019; 18: 551-556
- Cystic fibrosis-related diabetes is caused by islet loss and inflammation.JCI Insight. 2018; 3
- Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.Sci Rep. 2017; 717231
- CFTR influences beta cell function and insulin secretion through non-cell Autonomous exocrine-derived factors.Endocrinology. 2017; 158: 3325-3338
- Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.Clin Sci (Lond). 2015; 128: 131-142
- Islet interleukin-1beta Immunoreactivity is an early feature of cystic fibrosis that may contribute to beta-cell Failure.Diabetes Care. 2018; 41: 823-830
- Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.J Clin Invest. 2020; 130: 272-286
- Single-cell Transcriptome Profiling of human pancreatic islets in health and type 2 diabetes.Cell Metab. 2016; 24: 593-607
- A single-cell Transcriptomic Map of the human and mouse pancreas Reveals inter- and Intra-cell population Structure.Cell Syst. 2016; 3: 346-360 e4
- CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells.BMC Med. 2014; 12: 87
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.Pediatr Diabetes. 2013; 14: 417-421
- Islet hormone and incretin secretion in cystic fibrosis after Four Months of ivacaftor therapy.Am J Respir Crit Care Med. 2019; 199: 342-351
- Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries.J Cyst Fibros. 2020; 19: 68-79
- Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients.J Cyst Fibros. 2020; 19: 712-716
- Comment on "Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients.J Cyst Fibros. 2020; 19: 839
- Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients.J Cyst Fibros. 2021; 20: 333-338
Scully KJ, Marchetti P, Sawicki GS, Uluer A, Cernadas M, Cagnina RE, Kennedy JC, The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. Putman MS.J Cyst Fibros. 2022 Mar;21(2):258-263. doi: 10.1016/j.jcf.2021.09.001. Epub 2021 Sep 14.PMID: 34531155.
- PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy.J Cyst Fibros. 2021; 20: 205-212
- Genetic modifiers of cystic fibrosis-related diabetes have extensive Overlap with type 2 diabetes and related Traits.J Clin Endocrinol Metab. 2020; 105
- Genetic modifiers of cystic fibrosis-related diabetes.Diabetes. 2013; 62: 3627-3635
- Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.Nat Genet. 2012; 44: 562-569
- Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.Genet Med. 2021; 23: 927-933
- beta-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose >/=155 mg/dL.Pediatr Diabetes. 2018; 19: 1173-1182
- Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index.J Cyst Fibros. 2021; 20: 339-345
- Assessing the shape of the glucose curve during an oral glucose tolerance test.Diabetes Care. 2003; 26: 1026-1033
- One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.Diabetes Care. 2008; 31: 1650-1655
- Variation of glucose tolerance in adult patients with cystic fibrosis: what is the potential contribution of insulin sensitivity?.J Cyst Fibros. 2016; 15: 839-845
- Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis.J Cyst Fibros. 2020; 19: 139-145
- Overweight and obesity in patients with cystic fibrosis: a center-based analysis.Pediatr Pulmonol. 2015; 50: 35-41
- Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.N Engl J Med. 2019; 381: 1809-1819
- ISPAD Clinical Practice Consensus Guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents.Pediatr Diabetes. 2018; 19: 64-74
- Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline.Am J Respir Crit Care Med. 2000; 162: 891-895
- Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis.Eur J Pediatr. 1992; 151: 684-687
- Evaluation of glucose tolerance and insulin secretion in cystic fibrosis patients.Horm Res. 1998; 49: 65-71
Kilberg MJ, Harris C, Sheikh S, Stefanovski D, Cuchel M, Kubrak C, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis. J Clin Endocrinol Metab. 2020 Oct 1;105(10):3179-89. doi: 10.1210/clinem/dgaa448. PMID: 32668452; PMCID: PMC7755140.
- Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.J Cyst Fibros. 2020; 19: 310-315
- Monitoring of pediatric type 1 diabetes.Front Endocrinol (Lausanne). 2020; 11: 128
- Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.Diabetes Care. 2009; 32: 1020-1022
- Clinical targets for continuous glucose monitoring data Interpretation: recommendations from the International Consensus on time in range.Diabetes Care. 2019; 42: 1593-1603
- The relationships between time in range, hyperglycemia Metrics, and HbA1c.J Diabetes Sci Technol. 2019; 13: 614-626
- Perceptions of diabetes technology Use in cystic fibrosis-related diabetes management.Diabetes Technol Ther. 2021; 23: 753-759
- Use of the insulin pump in treat cystic fibrosis related diabetes.J Cyst Fibros. 2009; 8: 174-178
- Use of the Interoperable Artificial pancreas system for type 1 diabetes management during Psychological stress.J Diabetes Sci Technol. 2021; 15: 184-185
- Six-month randomized, Multicenter trial of Closed-Loop control in type 1 diabetes.N Engl J Med. 2019; 381: 1707-1717
- Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: a pilot study.J Cyst Fibros. 2020; 19: 159-161
- Clinical improvement in cystic fibrosis with early insulin treatment.Arch Dis Child. 2002; 87: 430-431
- Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance.J Endocrinol Invest. 2006; 29: RC1-RC4
- One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.Pediatr Diabetes. 2009; 10: 162-167
- Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.Diabetes Care. 2009; 32: 1783-1788
- Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial.Pediatr Diabetes. 2012; 13: 197-202
- Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.Lancet Diabetes Endocrinol. 2018; 6: 114-121
Kelly A, Sheikh S, Stefanovski D, Peleckis AJ, Nyirjesy SC, Eiel JN, Sidhaye A, Localio R, Gallop R, De Leon DD, Hadjiliadis D, Rubenstein RC, Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance. Rickels MR.J Clin Endocrinol Metab. 2021 Aug 18;106(9):2617-2634. doi: 10.1210/clinem/dgab365. Epub 2021 May 22.PMID: 34406395.
- Combined exercise training improves glycemic control in adult with cystic fibrosis.Med Sci Sports Exerc. 2017; 49: 231-237
- Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol.Trials. 2019; 20: 768
- Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.J Clin Endocrinol Metab. 2011; 96: E851-E855
- Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.J Clin Endocrinol Metab. 2014; 99: 2486-2493
- Incretin dysfunction and hyperglycemia in cystic fibrosis: role of acyl-ghrelin.J Cyst Fibros. 2019; 18: 557-565
- Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial.Diabetes Obes Metab. 2019; 21: 700-704
Olatunbosun ST. Chronic incretin-based therapy in cystic fibrosis-related diabetes: A tale of 3 patients treated with sitagliptin for over 5 years. J Cyst Fibros. 2021 Nov;20(6):e124-e128. doi: 10.1016/j.jcf.2021.02.005. Epub 2021 Mar 2. PMID: 33674210.
- Demineralization in cystic fibrosis detected by direct photon absorptiometry.Am J Dis Child. 1979; 133: 632-635
- Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.Ann Intern Med. 1998; 128: 186-193
- Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.J Pediatr. 2005; 147: 327-331
- Sternal fracture with fatal outcome in cystic fibrosis.Thorax. 2005; 60: 616
Foundation CF. Cystic Fibrosis Foundation Patient Registry 2019 Annual Data Report. Bethesda (MD): 2020.
- Guide to bone health and disease in cystic fibrosis.J Clin Endocrinol Metab. 2005; 90: 1888-1896
- Abnormal bone turnover in cystic fibrosis adults.Osteoporos Int. 2002; 13: 151-157
- Altered calcium homeostasis in adults with cystic fibrosis.Osteoporos Int. 1999; 10: 102-108
- Vitamin d deficiency in cystic fibrosis.Int J Endocrinol. 2010; 2010218691
- Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.Endocrinology. 1999; 140: 4382-4389
- Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.J Clin Invest. 1998; 101: 2598-2605
- Bone density, body composition, and inflammatory status in cystic fibrosis.Am J Respir Crit Care Med. 2000; 162: 789-794
- Inflammatory related changes in bone mineral content in adults with cystic fibrosis.Thorax. 2004; 59: 613-617
- Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis.J Cyst Fibros. 2010; 9: 93-98
- Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.Am J Respir Crit Care Med. 2006; 174: 306-311
- Amenorrhoea in cystic fibrosis.Clin Endocrinol (Oxf). 1987; 26: 187-195
- Sex steroids and body composition in men with cystic fibrosis.Eur J Endocrinol. 2003; 148: 551-557
- The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis.Clin Endocrinol (Oxf). 2013; 78: 36-42
- Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.Osteoporos Int. 2006; 17: 783-790
- Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.Bone. 2004; 35: 771-776
- Cystic fibrosis Foundation patient Registry, 2019.Annual Data Report, Bethesda, MD2020
- Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.Eur Respir J. 2005; 25: 54-61
- IL-8 correlates with reduced baseline femoral neck bone mineral density in adults with cystic fibrosis: a single center retrospective study.Sci Rep. 2021; 1115405
- Relationship between estrogen treatment and Skeletal health in women with cystic fibrosis.Am J Med Sci. 2020; 360: 581-590
- Severe osteopenia in CFTR-null mice.Bone. 2004; 35: 595-603
- Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice.Am J Respir Crit Care Med. 2008; 177: 309-315
- Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.Pediatr Res. 2009; 65: 311-316
- The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.Am J Pathol. 2012; 180: 2068-2075
- Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth.Proc Natl Acad Sci U S A. 2010; 107: 20571-20575
- The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis.J Clin Endocrinol Metab. 2021; 106: e1248-e1261
- An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.J Clin Endocrinol Metab. 2012; 97: 1082-1093
- Bisphosphonates for osteoporosis in people with cystic fibrosis.Cochrane Database Syst Rev. 2012; 4: CD002010
- Growth hormone improves bone mineral content in children with cystic fibrosis.J Pediatr Endocrinol Metab. 2005; 18: 589-595
- Cystic fibrosis bone disease treatment: Current knowledge and future directions.J Cyst Fibros. 2019; 18: S56-S65
- BMI fails to identify poor nutritional status in stunted children with CF.J Cyst Fibros. 2017; 16: 158-160
- Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.Pediatr Pulmonol. 2009; 44: 209-215
- Early-life height Attainment in cystic fibrosis is associated with pulmonary function at age 6 Years.Ann Am Thorac Soc. 2021; 18: 1335-1342
- Stunting is an independent predictor of mortality in patients with cystic fibrosis.Clin Nutr. 2013; 32: 382-385
- Growth and the growth hormone-insulin like growth factor 1 Axis in children with chronic inflammation: Current evidence, Gaps in knowledge, and future directions.Endocr Rev. 2016; 37: 62-110
- Mouse as a model of growth retardation in cystic fibrosis.Pediatr Res. 2006; 59: 191-195
- Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.PLoS One. 2017; 12e0188497
- Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.J Endocrinol Invest. 2018; 41: 591-596
- Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.Pediatr Pulmonol. 2014; 49: 335-341
- Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first Year of life.JAMA Pediatr. 2017; 171: 546-554
- Growth in prepubertal children with cystic fibrosis treated with ivacaftor.Pediatrics. 2017; 139
- A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis.Pediatr Pulmonol. 2012; 47: 252-263
- Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis.J Pediatr. 2013; 163: 376-382
- Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis.Pediatr Res. 2021; 89: 653-659
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
